Aemetis (NASDAQ:AMTX) Upgraded at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a research note issued to investors on Monday morning.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Price Performance

NASDAQ AMTX opened at $2.30 on Monday. Aemetis has a 1-year low of $2.04 and a 1-year high of $7.03. The business has a 50 day simple moving average of $3.00 and a two-hundred day simple moving average of $2.91. The stock has a market capitalization of $114.39 million, a PE ratio of -1.02 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last posted its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to analysts’ expectations of $77.79 million. During the same period last year, the business posted ($0.59) earnings per share. On average, analysts anticipate that Aemetis will post -2.07 EPS for the current fiscal year.

Institutional Investors Weigh In On Aemetis

Several large investors have recently modified their holdings of the business. Geode Capital Management LLC lifted its stake in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after purchasing an additional 66,031 shares during the last quarter. State Street Corp raised its holdings in Aemetis by 36.1% in the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares in the last quarter. Barclays PLC lifted its position in shares of Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after buying an additional 34,816 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after buying an additional 50,528 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC grew its position in shares of Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after buying an additional 93,536 shares during the last quarter. Institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.